Hinge Health

Sacra estimates Hinge Health hit $390M in revenue in 2024, growing 33% year-over-year from $293M in 2023.

Hinge Health primarily generates revenue from self-insured employers through annual subscriptions, with clients only paying for members who engage with their MSK programs. Revenue is recognized ratably over 12 months once members enroll. The company has recently introduced an engagement-based pricing model with an upfront platform fee plus per-session charges.

With 2,256 clients as of December 31, 2024 (up 36% YoY), Hinge Health serves 49% of Fortune 100 companies and 42% of Fortune 500 companies. Their impressive 98% client retention rate and 117% net dollar retention demonstrate strong customer satisfaction and expansion.

The company is actively diversifying revenue streams by expanding into fully-insured employers and Medicare Advantage markets through partnerships with five national health plans. Their international expansion began with Canada in Q3 2024, with European launches planned for 2025.

Hinge Health's financial profile has strengthened significantly, with gross margins improving from 66% in 2023 to 77% in 2024. The company generated $49M in operating cash flow and $45M in free cash flow in 2024, while reducing its net loss by 89% to just $12M.

Hinge Health raised $437M in its IPO on May 21, 2025, pricing at $32 per share (13.666M shares). Shares closed at $37.56 on the first day of trading (May 22, 2025), implying an approximate market cap of ~$3B — a significant reset from its $6.2B private valuation following the $600M Series E in October 2021, led by Tiger Global and Coatue Management. Total funding raised prior to the IPO was $1.05B.

Based on FY2025 revenue of $587.9M and FY2026 guidance of $732M–$742M, the company's ~$3B first-day market cap implied approximately 5.1x LTM revenue and ~4.1x forward revenue.

Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg to address musculoskeletal (MSK) pain through digital physical therapy.

Hinge Health found product-market fit as a digital MSK care platform for self-insured employers seeking to reduce healthcare costs while improving employee outcomes for conditions like back and knee pain.

The platform delivers personalized physical therapy programs through a mobile app, combining AI-powered motion tracking technology with clinical support. Members receive a kit with wearable sensors that provide real-time feedback during exercises, ensuring proper form. The platform's computer vision technology tracks over 100 points on the body to assess joint angles, symmetry, and endurance — measuring range of motion and guiding form corrections in real time through a capability called Movement Analysis. Members also have access to Robin, an AI care assistant that provides instant support, backed by the company's published AI care principles.

Care is designed by physical therapists but largely automated through AI, allowing members to engage on-demand without scheduling constraints. The platform addresses the full spectrum of MSK needs, from prevention to chronic pain management and post-surgical rehabilitation.

Hinge Health has expanded its offerings to include:

The platform is typically offered at no direct cost to members, fully covered by their employers or health plans.

Hinge Health is a digital musculoskeletal (MSK) care platform that connects self-insured employers and health plans with comprehensive solutions for treating and preventing joint and muscle pain. The company operates on an annual subscription model where clients pay only for members who actively engage with their programs.

Revenue is generated through an engagement-based pricing structure that typically includes an annual upfront platform fee per eligible member plus additional fees for completed therapy sessions. Hinge Health has also introduced alternative pricing models, including milestone-based payments tied to member engagement.

The platform leverages AI-powered motion tracking technology to automate personalized care plans, reducing human physical therapy hours by approximately 95% while maintaining high-quality outcomes. This technology-first approach enables Hinge Health to achieve gross margins of approximately 81% on a GAAP basis as of Q1 2025.

Hinge Health primarily targets self-insured employers, including 49% of Fortune 100 and 42% of Fortune 500 companies, and has expanded distribution through a collaboration with Cigna Healthcare to broaden access to its MSK offering nationwide. The company is actively expanding into fully-insured employers, Medicare Advantage markets, and federal insurance plans through strategic partnerships with all five major national health plans.

The sales cycle averages 5 months but can exceed 12 months for larger enterprise clients. Most contracts are secured in the second half of the calendar year to align with employee benefit enrollment periods, with platform launches typically occurring in the first half of the following year.

FY2025 marked a profitability inflection for Hinge Health, with non-GAAP income from operations reaching $119.5M (versus a $26.1M non-GAAP operating loss in 2024) and free cash flow growing 297% to $179.6M. With nearly $500M in cash and investments at end of Q3 2025, the company authorized a $250M share repurchase program in November 2025 and guides FY2026 non-GAAP income from operations of $151M–$156M.

Hinge Health operates in a market that includes digital musculoskeletal (MSK) care providers, traditional physical therapy networks, and integrated healthcare platforms. The competitive landscape has evolved rapidly as employers and health plans seek solutions to address the $1.3 trillion annual burden of MSK conditions in the United States.

Sword Health offers a similar digital physical therapy solution with motion tracking technology and virtual care teams. Unlike Hinge Health's comprehensive platform approach, Sword focuses primarily on physical therapy and pain management.

SWORD has raised significant funding ($163M Series D in 2021) but lacks Hinge Health's scale of 20 million contracted lives and partnerships with all five major national health plans.

Kaia Health provides a smartphone-based solution that uses computer vision for movement tracking without specialized sensors. Their approach offers greater accessibility but potentially less precision than Hinge Health's TrueMotion technology.

RecoveryOne (formerly Trainer Rx) focuses on virtual MSK recovery with personalized exercise programs and telehealth coaching. They differentiate by emphasizing recovery from specific injuries rather than Hinge Health's broader chronic pain management approach.

Major physical therapy chains like ATI Physical Therapy, Select Physical Therapy, and CORA Health Services represent the traditional in-person approach to MSK care. These providers typically operate through insurance networks with higher patient costs and less convenience than digital solutions.

Traditional providers have begun incorporating telehealth components, particularly following COVID-19, but lack the AI-driven personalization and motion tracking capabilities of digital-first platforms.

Omada Health started as a digital diabetes prevention program but has expanded into MSK care through its 2020 acquisition of Physera. This positions them as a comprehensive digital health solution addressing multiple chronic conditions.

Teladoc Health offers virtual MSK care as part of its broader telehealth platform. Their acquisition of Livongo (2020) strengthened their chronic condition management capabilities, though their MSK offering lacks the specialized technology and depth of Hinge Health.

Grand Rounds Health (now Included Health) provides navigation services connecting patients to appropriate care, including MSK specialists. They compete less directly but influence referral patterns to specialized MSK providers.

Major health insurers have also developed in-house digital MSK programs, though these typically lack the technological sophistication of dedicated providers like Hinge Health. UnitedHealth Group's Optum has invested significantly in virtual care capabilities that include MSK management.

Hinge Health has tailwinds from the massive MSK care market, digital health adoption, and value-based care trends. The company has the opportunity to grow and expand into adjacent markets like women's health, global markets, and Medicare/Medicaid populations.

Hinge Health has grown contracted lives to 25 million (up from 20 million in 2024) and surpassed 1.5 million lifetime members as of Q3 2025, while still addressing only a fraction of its total addressable market. The MSK care market represents a $661 billion annual direct spend in the U.S. alone, with an additional $624 billion in indirect costs. The company's current self-insured employer market represents approximately $10 billion in opportunity, and with 98% client retention and 117% net dollar retention, Hinge demonstrates strong product-market fit within its core business — already securing 49% of Fortune 100 and 42% of Fortune 500 companies as clients.

Fully-insured employers and Medicare Advantage plans represent an $8 billion addressable market with 96 million additional lives. Hinge has expanded into these markets through partnerships with all five major national health plans, with the fall prevention program specifically targeting Medicare Advantage populations. Government agencies and healthcare programs (Medicare/Medicaid) offer another $9 billion opportunity with 112 million lives.

Women's health represents a significant expansion opportunity. Hinge launched a women's pelvic health program in 2022 and expanded to menopause support in 2024, addressing underserved segments with specialized MSK care needs.

Hinge Health has entered Canada and several European markets, with the company's AI-driven approach reducing reliance on human providers and enabling more efficient cross-border scaling. The global MSK market is substantial, with an estimated 1.7 billion people worldwide affected by MSK conditions.

Employer benefit concentration: Hinge Health's revenue is heavily reliant on self-insured employers, and any significant shift in how employers approach healthcare benefits or cost-cutting during economic downturns could materially impact growth. Expansion into health plans and Medicare Advantage partially diversifies this exposure but those channels remain early-stage.

Public company cost structure and SBC overhang: The IPO triggered $591M in stock-based compensation expense in the GAAP P&L, creating a significant gap between GAAP and non-GAAP profitability that complicates comparisons and investor perception. Sustained elevated SBC could weigh on GAAP earnings and dilute shareholders even as non-GAAP metrics improve.

Competitive commoditization of digital MSK care: As Hinge expands into Medicare Advantage, international markets, and hybrid in-person care via HingeSelect, it faces increasing competition from digital health startups and traditional providers building similar capabilities. Replication of its AI motion-tracking technology could erode its premium pricing position and high gross margins.